Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) insider Carmen Jeffrey Del sold 7,541 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $16.07, for a total transaction of $121,183.87. Following the completion of the sale, the insider now owns 18,427 shares of […]
Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Friday. Several other analysts also recently commented on CPRX. Oppenheimer reaffirmed an “outperform” rating and set a $29.00 target price on shares of Catalyst Pharmaceuticals in a […]
Cantor Fitzgerald restated their overweight rating on shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) in a report published on Friday, Benzinga reports. They currently have a $34.00 target price on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on CPRX. TheStreet raised shares of Catalyst Pharmaceuticals from a c+ […]
Insider Selling: Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Director Sells 50,000 Shares of Stock etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Catalyst Pharmaceuticals (CPRX) Scheduled to Post Quarterly Earnings on Wednesday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.